• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

泰国清迈1993 - 1997年癌症生存率。

Cancer survival in Chiang Mai, Thailand, 1993-1997.

作者信息

Sumitsawan Y, Srisukho S, Sastraruji A, Chaisaengkhum U, Maneesai P, Waisri N

机构信息

Chiang Mai Tumour Registry, Maharaj Nakorn Chiang Mai Hospital, Faculty of Medicine, Chiang Mai University, Thailand.

出版信息

IARC Sci Publ. 2011(162):199-209.

PMID:21675424
Abstract

The Chiang Mai tumour registry was established in 1978 as a hospital-based cancer registry, and population-based cancer registration started in 1986, with retrospective data collection on cancer incidence and mortality since 1983. Registration of cases is done by active methods. Data on survival for 36 cancer sites or types registered during 1993-1997 are reported here. Follow-up has been carried out predominantly by active methods, with median follow-up ranging between 1-39 months for different cancers. The proportion of histologically verified diagnosis for various cancers ranged between 28-100%; death certificate only (DCO) cases comprised 0-56%; 33-92% of total registered cases were included for survival analysis. Complete followup at five years ranged from 59-100% for different cancers. The 5-year age-standardized relative survival rates was the highest for Hodgkin lymphoma (70%) followed by thyroid (65%), cervix (57%), breast (56%) and corpus uteri (49%). The 5-year relative survival by age group showed either an inverse relationship or was fluctuating. An overwhelmingly high proportion of cases were diagnosed with a regional spread of disease, ranging between 44-82% for different cancers and survival decreased with increasing extent of disease for all cancers studied.

摘要

清迈肿瘤登记处成立于1978年,是一个基于医院的癌症登记处,基于人群的癌症登记始于1986年,自1983年起开始回顾性收集癌症发病率和死亡率数据。病例登记通过主动方法进行。本文报告了1993 - 1997年期间登记的36个癌症部位或类型的生存数据。随访主要通过主动方法进行,不同癌症的中位随访时间在1 - 39个月之间。各种癌症经组织学证实诊断的比例在28% - 100%之间;仅死亡证明(DCO)病例占0% - 56%;纳入生存分析的病例占总登记病例的33% - 92%。不同癌症的五年完全随访率在59% - 100%之间。霍奇金淋巴瘤的5年年龄标准化相对生存率最高(70%),其次是甲状腺癌(65%)、宫颈癌(57%)、乳腺癌(56%)和子宫体癌(49%)。按年龄组划分的5年相对生存率呈反比关系或波动变化。绝大多数病例被诊断为疾病区域扩散型,不同癌症的这一比例在44% - 82%之间;在所研究的所有癌症中,生存率随疾病范围扩大而降低。

相似文献

1
Cancer survival in Chiang Mai, Thailand, 1993-1997.泰国清迈1993 - 1997年癌症生存率。
IARC Sci Publ. 2011(162):199-209.
2
Cancer survival in Lampang, Thailand, 1990-2000.泰国南邦府1990 - 2000年癌症生存率。
IARC Sci Publ. 2011(162):217-26.
3
Cancer survival in Songkhla, Thailand, 1990-1999.泰国宋卡1990 - 1999年的癌症生存率。
IARC Sci Publ. 2011(162):227-35.
4
Cancer survival in Khon Kaen, Thailand, 1993-1997.1993 - 1997年泰国孔敬府的癌症生存率
IARC Sci Publ. 2011(162):211-6.
5
Cancer survival in Mumbai (Bombay), India, 1992-1999.1992 - 1999年印度孟买(旧称: Bombay)的癌症生存率。
IARC Sci Publ. 2011(162):133-42.
6
Cancer survival in Izmir, Turkey, 1995-1997.1995 - 1997年土耳其伊兹密尔的癌症生存率
IARC Sci Publ. 2011(162):237-42.
7
Cancer survival in Chennai (Madras), India, 1990-1999.印度钦奈(马德拉斯)1990 - 1999年癌症生存率
IARC Sci Publ. 2011(162):115-24.
8
Cancer survival in Kampala, Uganda, 1993-1997.1993 - 1997年乌干达坎帕拉的癌症生存率
IARC Sci Publ. 2011(162):243-7.
9
Cancer survival in Cuba, 1994-1995.1994 - 1995年古巴的癌症生存率
IARC Sci Publ. 2011(162):89-95.
10
Cancer survival in Harare, Zimbabwe, 1993-1997.1993 - 1997年津巴布韦哈拉雷的癌症生存率
IARC Sci Publ. 2011(162):249-55.

引用本文的文献

1
Global Research Trends in Cervical Cancer Survival in the Last Two Decades: A Bibliometric Analysis.过去二十年宫颈癌生存率的全球研究趋势:一项文献计量分析
Malays J Med Sci. 2024 Dec;31(6):103-111. doi: 10.21315/mjms2024.31.6.8. Epub 2024 Dec 31.
2
Survival rate of cervical cancer: a five year review at a Major Teaching Hospital in Ghana, West Africa.宫颈癌生存率:西非加纳一家主要教学医院的五年回顾
Ecancermedicalscience. 2024 Feb 1;18:1663. doi: 10.3332/ecancer.2024.1663. eCollection 2024.
3
Evaluation of Survival Rate and Associated Factors in Patients with Cervical Cancer: A Retrospective Cohort Study.
宫颈癌患者生存率评估及相关因素分析:一项回顾性队列研究。
J Res Health Sci. 2022 Jun 30;22(2):e00552. doi: 10.34172/jrhs.2022.87.
4
The survival rate of hepatocellular carcinoma in Asian countries: a systematic review and meta-analysis.亚洲国家肝细胞癌的生存率:一项系统评价与荟萃分析。
EXCLI J. 2020 Jan 13;19:108-130. doi: 10.17179/excli2019-1842. eCollection 2020.
5
Survival Rate of Prostate Cancer in Asian Countries: A Systematic Review and Meta-Analysis.亚洲国家前列腺癌的生存率:一项系统评价与荟萃分析。
Ann Glob Health. 2020 Jan 2;86(1):2. doi: 10.5334/aogh.2607.
6
Improved Survival of Cervical Cancer Patients in a Screened Population in Rural India.印度农村筛查人群中宫颈癌患者生存率的提高。
Asian Pac J Cancer Prev. 2016 Nov 1;17(11):4837-4844. doi: 10.22034/APJCP.2016.17.11.4837.